These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4052953)

  • 1. Effect of smoking on human natural killer cell activity.
    Phillips B; Marshall ME; Brown S; Thompson JS
    Cancer; 1985 Dec; 56(12):2789-92. PubMed ID: 4052953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of natural killer cytotoxic activity in major depression: interaction between depression and cigarette smoking.
    Jung W; Irwin M
    Psychosom Med; 1999; 61(3):263-70. PubMed ID: 10367603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer (NK) cell activity in patients with various malignancy against a variety of target cell lines: re-evaluation of clinical significance of natural killer cell activity.
    Morikawa K; Nakano A; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(4):462-70. PubMed ID: 2810919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic cell function in bronchogenic carcinoma.
    Kratikanont P; deShazo RD; Banks DE; Chapman Y
    Chest; 1987 Jul; 92(1):90-4. PubMed ID: 3595254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.
    Terazawa A; Tanaka N; Senou N; Inoue F; Matsuura H; Gouchi A; Fuchimoto S; Mimura H; Orita K
    Jpn J Surg; 1987 Jul; 17(4):236-42. PubMed ID: 3682431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of smoking on natural killer cell activity in the lung.
    Takeuchi M; Nagai S; Izumi T
    Chest; 1988 Oct; 94(4):688-93. PubMed ID: 3262485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activity in cigarette smokers and asbestos workers.
    Ginns LC; Ryu JH; Rogol PR; Sprince NL; Oliver LC; Larsson CJ
    Am Rev Respir Dis; 1985 Jun; 131(6):831-4. PubMed ID: 4003932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of natural killer cells in lung cancer.
    Aktaş ON; Öztürk AB; Erman B; Erus S; Tanju S; Dilege Ş
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):997-1003. PubMed ID: 29616326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface antigens and cytotoxic natural killer cell (NK) activity of blood lymphocytes in heavy cigarette smokers.
    Jezewska E; Dworacki G; Skrzypczak A; Zeromski J
    Arch Geschwulstforsch; 1990; 60(3):187-92. PubMed ID: 2369281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of natural killer cell activity by surgical stress in cancer patients and the underlying mechanisms.
    Yoshihara H; Tanaka N; Orita K
    Acta Med Okayama; 1986 Apr; 40(2):113-9. PubMed ID: 2940814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished natural killer-cell activity of interstitial pulmonary cell populations from patients with carcinoma of the lung.
    deShazo RD; Moulder PV; Bozelka B; Chapman Y
    Chest; 1987 Jan; 91(1):26-8. PubMed ID: 3792080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with primary lung cancer.
    Kim SK; Cho CH; Ahn CM; Jang SH; Lee YH; Kim SK; Chang J; Lee BK; Kim SJ; Youn JK
    Yonsei Med J; 1992 Mar; 33(1):41-7. PubMed ID: 1502829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
    Pitchenik AE; Guffee J; Stein-Streilein J
    Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant drugs increase natural killer cell activity in lung cancer.
    Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
    Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer cell activity in lung cancer.
    LeFever A; Funahashi A
    Chest; 1991 Feb; 99(2):292-7. PubMed ID: 1989785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of C-reactive protein on natural killer activity].
    Shibuya M; Saijo N; Shimizu E; Taniguchi T; Takizawa T; Fujioka H; Hoshi A
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2341-6. PubMed ID: 6639096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.